BTGin Co., Ltd. has been proudly established as a Bioventure company in Daejeon, Korea for human health and happiness by developing Biotechnology with ginseng products like ginsenosides and producing new medical materials in 2002.

Recently due to the strong possibility of pharmaceutical use for ginseng and ginsenosides, the world-wide trade market of ginseng is remarkably increasing and more competitive. To use the main component of ginseng for new medicine and nutraceuticals, BTGin has been developed the enzyme technology by which new ginsenosides and effective ginseng components which have been produced through the transformation of ginseng structure.

BTGin is a sole company which has a specific technology to manufacture and modify more than 30 pure single ginsenosides including Rd, F1, F2, Rg3, Rg2, Rh1, Rh2, Mc, Mc1, Compound K, Y, O, aglycone PPD, PPT in a mass production.

Furthermore, BTGin Co., Ltd. possesses its own technology to examine the qualities of various ginseng products. Also BTGin is manufacturing various glyco-products such as functional food and cosmetic materials by applying its high technologies. Based on the management motto “Creation of unlimited value through free competition”,

BTGin will be the leader of biotechnology in the world.